PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,535,921 | -44.9% | 291,652 | 0.0% | 0.05% | -46.5% |
| Q2 2023 | $11,861,487 | -4.2% | 291,652 | +5.0% | 0.09% | 0.0% |
| Q1 2023 | $12,379,275 | +60.0% | 277,652 | +37.0% | 0.09% | +65.4% |
| Q4 2022 | $7,734,864 | -24.0% | 202,652 | 0.0% | 0.05% | -27.8% |
| Q3 2022 | $10,174,000 | +25.3% | 202,652 | 0.0% | 0.07% | +7.5% |
| Q2 2022 | $8,118,000 | -20.4% | 202,652 | -25.9% | 0.07% | -2.9% |
| Q1 2022 | $10,199,000 | -6.3% | 273,374 | 0.0% | 0.07% | 0.0% |
| Q4 2021 | $10,888,000 | +7.0% | 273,374 | 0.0% | 0.07% | 0.0% |
| Q3 2021 | $10,172,000 | -12.0% | 273,374 | 0.0% | 0.07% | -12.7% |
| Q2 2021 | $11,556,000 | -67.1% | 273,374 | -54.4% | 0.08% | -72.9% |
| Q1 2021 | $35,139,000 | -3.9% | 599,397 | 0.0% | 0.29% | +1.0% |
| Q4 2020 | $36,583,000 | +4.3% | 599,397 | -20.1% | 0.29% | -12.2% |
| Q3 2020 | $35,059,000 | -10.7% | 749,960 | -3.1% | 0.33% | -20.7% |
| Q2 2020 | $39,272,000 | +38.9% | 773,960 | +28.6% | 0.42% | +32.6% |
| Q1 2020 | $28,264,000 | -2.2% | 601,990 | 0.0% | 0.31% | +1.0% |
| Q4 2019 | $28,914,000 | +23.8% | 601,990 | -12.8% | 0.31% | +0.3% |
| Q3 2019 | $23,353,000 | -18.6% | 690,523 | +7.8% | 0.31% | -13.7% |
| Q2 2019 | $28,697,000 | +64.8% | 640,523 | +38.5% | 0.36% | +60.5% |
| Q1 2019 | $17,410,000 | +26.0% | 462,523 | +14.9% | 0.22% | +5.2% |
| Q4 2018 | $13,814,000 | -9.7% | 402,523 | +23.7% | 0.21% | +4.4% |
| Q3 2018 | $15,300,000 | +190.8% | 325,523 | +108.7% | 0.20% | +144.6% |
| Q2 2018 | $5,262,000 | +59.4% | 156,000 | +27.9% | 0.08% | +48.2% |
| Q1 2018 | $3,301,000 | +127.5% | 122,000 | +40.2% | 0.06% | +124.0% |
| Q4 2017 | $1,451,000 | +20.8% | 87,000 | +45.0% | 0.02% | +19.0% |
| Q3 2017 | $1,201,000 | -37.2% | 60,000 | +1.7% | 0.02% | -58.8% |
| Q4 2015 | $1,912,000 | -3.2% | 59,000 | -20.3% | 0.05% | +4.1% |
| Q3 2015 | $1,976,000 | -37.8% | 74,000 | +12.1% | 0.05% | -25.8% |
| Q2 2015 | $3,177,000 | -46.2% | 66,000 | -32.0% | 0.07% | -44.5% |
| Q1 2015 | $5,904,000 | +14.0% | 97,000 | -3.0% | 0.12% | +10.2% |
| Q4 2014 | $5,177,000 | – | 100,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |